[Cholangitis and biliary sepsis: problem and ways of solution]

Area of Science:

• Hepatology
• Infectious Diseases
• Critical Care Medicine

Background:

• Acute cholangitis and biliary sepsis are critical conditions requiring precise management.
• Distinguishing between these closely related diagnoses is essential for effective treatment.
• Current treatment strategies may not fully address the complexities of biliary sepsis.

Purpose of the Study:

• To establish clear distinctions and interrelationships between acute cholangitis and biliary sepsis.
• To develop and evaluate a novel, stratified treatment strategy for patients with hyperbilirubinemia.
• To assess the impact of this new strategy on patient outcomes and healthcare costs.

Main Methods:

• Patients with hyperbilirubinemia were categorized into four distinct groups.
• Inclusion criteria were based on specific patient characteristics and disease severity.
• A new, group-specific treatment strategy was implemented, guided by procalcitonin levels.

Main Results:

• The novel treatment strategy led to significantly lower lethality rates.
• Patients experienced shorter hospital stays compared to previous management approaches.
• The cost of treatment was demonstrably reduced across all patient groups.

Conclusions:

• The study successfully differentiated acute cholangitis from biliary sepsis, highlighting their interrelationship.
• Procalcitonin levels serve as a key biomarker for stratifying patients and guiding treatment.
• The implemented strategy offers a more effective and cost-efficient approach to managing hyperbilirubinemia in these critical conditions.